Ocular tuberculosis can affect any part of the eye, from the conjunctiva to the optic nerve. Despite recent advances in diagnostic technologies, it continues to be a challenge to positively diagnose TB.
Technological breakthroughs, such as quantitative polymerase chain reaction (qPCR), are becoming the diagnostic method of choice due to rapid test results and the ability to test very small tissue samples. Once the appropriate treatment begins, ocular inflammation quickly improves. Early diagnosis and treatment are essential in preventing recurrences.
Complete this module to:
- Identify significant clinical features of ocular tuberculosis.
- Summarize the rationale of important microbiologic, histopathologic, molecular and radiographic tests in the workup of tuberculosis.
- Describe treatment modalities for ocular tuberculosis.
Author: S. R. Rathinam, FAMS, PhD
Consultants: Moncef Khairallah, MD; Narsing A. Rao, MD
Focal Points issues are practical, hands-on discussions of the clinical issues you face daily. Each issue delivers high-quality, trusted ophthalmic information written and reviewed by leading experts.
Subscribers receive 12 issues a year, plus access to the Focal Points digital archive.
To access this issue from your laptop or desktop computer, log in to www.aao.org/myonlineproducts with your Academy username and password.
To access this issue from your smartphone or tablet, use the free AAO eBooks app.
The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.